
Join to View Full Profile
8700 Beverly BlvdSte 5512West Hollywood, CA 90048
Phone+1 310-423-5161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Publications & Presentations
PubMed
- 3 citationsThe JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma.Ning Xu, Erin Yu, Nicole Ng, Mingjie Li, Sean Bujarski
Hematological Oncology. 2023-08-01 - 21 citationsRuxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand-1 (PD-L1) expression and increases anti-tumour effects of T cells in multiple myelomaHaiming Chen, Mingjie Li, Nicole Ng, Erin Yu, Sean Bujarski
British Journal of Haematology. 2021-02-01 - 46 citationsJAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression.Haiming Chen, Mingjie Li, Eric Sanchez, Camilia Soof, Sean Bujarski
British Journal of Haematology. 2020-01-01